Pharmaceutical Investing Pfizer's Abrocitinib Receives Positive CHMP Opinion for the Treatment of Adults with Moderate to Severe Atopic Dermatitis
Pharmaceutical Investing Merck and Eisai Receive Positive EU CHMP Opinions for KEYTRUDA® Plus LENVIMA® in Two Different Types of Cancer
Pharmaceutical Investing Merck Receives Positive CHMP Opinion for VAXNEUVANCE in Individuals 18 Years of Age and Older
Bristol Myers Squibb Receives Positive CHMP Opinion for Zeposia as a Treatment for Adult Patients with Moderately to Severely Active Ulcerative Colitis
Feel Foods Ltd. Adds Additional Western Canada Distributor and Receives Initial Order for “Black Sheep Vegan Cheeze” Products
CEO Interviews Sirona Biochem CEO: Unique Opportunity for Global Success in the Cosmetic and Therapeutic Spaces
Medical Device Investing Johnson & Johnson Ovarian Cancer Victims Vow Fight to Stop J&J's Bankruptcy Scheme
Medical Device Investing Johnson & Johnson Takes Steps to Equitably Resolve All Current and Future Talc Claims
Contakt World Expands Commercial Portfolio Through Partnership Agreement with Portum for Health Screening, Vaccine Wallet, Vaccine Passport, and More
Life Science Investing Sixth Wave Presents Affinity Extraction Technology at the Premiere Gathering of North America Cannabis Entrepreneurs
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain Metastasis
